Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 1
2007 1
2008 1
2009 3
2010 5
2011 3
2012 2
2013 4
2014 4
2015 4
2016 5
2017 8
2018 13
2019 7
2020 10
2021 12
2022 10
Text availability
Article attribute
Article type
Publication date

Search Results

86 results
Results by year
Filters applied: . Clear all
Page 1
BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemia.
Kong W, Dimitri A, Wang W, Jung IY, Ott CJ, Fasolino M, Wang Y, Kulikovskaya I, Gupta M, Yoder T, DeNizio JE, Everett JK, Williams EF, Xu J, Scholler J, Reich TJ, Bhoj VG, Haines KM, Maus MV, Melenhorst JJ, Young RM, Jadlowsky JK, Marcucci KT, Bradner JE, Levine BL, Porter DL, Bushman FD, Kohli RM, June CH, Davis MM, Lacey SF, Vahedi G, Fraietta JA. Kong W, et al. J Clin Invest. 2021 Aug 16;131(16):e145459. doi: 10.1172/JCI145459. J Clin Invest. 2021. PMID: 34396987 Free PMC article.
Biomarkers in chimeric antigen receptor T-cell therapy.
Kong W, Lacey SF, Melenhorst JJ, Fraietta JA. Kong W, et al. Biomark Med. 2018 May;12(5):415-418. doi: 10.2217/bmm-2018-0054. Epub 2018 Apr 26. Biomark Med. 2018. PMID: 29697279 Free article. No abstract available.
Reversal of obesity-driven aggressiveness of endometrial cancer by metformin.
Guo H, Kong W, Zhang L, Han J, Clark LH, Yin Y, Fang Z, Sun W, Wang J, Gilliam TP, Lee D, Makowski L, Zhou C, Bae-Jump VL. Guo H, et al. Among authors: kong w. Am J Cancer Res. 2019 Oct 1;9(10):2170-2193. eCollection 2019. Am J Cancer Res. 2019. PMID: 31720081 Free PMC article.
86 results